|
humans |
21 |
|
male |
15 |
|
middle aged |
15 |
|
female |
12 |
|
bone marrow - pathology |
11 |
|
immunoglobulin heavy chains - genetics |
11 |
|
base sequence |
10 |
|
diagnosis, differential |
10 |
|
molecular sequence data |
10 |
|
prognosis |
10 |
|
antigens, cd44 - genetics - metabolism |
9 |
|
lymphoma - genetics |
9 |
|
lymphoma, follicular - genetics - pathology |
9 |
|
lymphoma, large b-cell, diffuse - genetics - pathology |
9 |
|
stomach neoplasms - genetics - pathology |
9 |
|
adult |
8 |
|
dna methylation |
8 |
|
karyotyping |
8 |
|
mutation |
8 |
|
promoter regions, genetic |
8 |
|
adolescent |
7 |
|
aged |
7 |
|
aged, 80 and over |
7 |
|
child |
7 |
|
dna mutational analysis |
7 |
|
polymerase chain reaction |
7 |
|
recurrence |
7 |
|
sequence homology, nucleic acid |
7 |
|
chinese |
6 |
|
family health |
6 |
|
flow cytometry |
6 |
|
acquired immunodeficiency syndrome - complications - diagnosis |
5 |
|
acute promyelocytic leukaemia |
5 |
|
antineoplastic combined chemotherapy protocols - therapeutic use |
5 |
|
child, preschool |
5 |
|
chromosomes, human, pair 6 - genetics |
5 |
|
cryptococcosis - diagnosis - etiology |
5 |
|
cytogenetics |
5 |
|
disease progression |
5 |
|
dna-binding proteins - biosynthesis - genetics |
5 |
|
epigenesis, genetic - genetics |
5 |
|
gene expression regulation, neoplastic |
5 |
|
genotype |
5 |
|
hematologic neoplasms - genetics |
5 |
|
heterozygote |
5 |
|
immunoglobulins - chemistry |
5 |
|
immunophenotyping |
5 |
|
leukemia, lymphocytic, chronic, b-cell - genetics |
5 |
|
lymphatic diseases - diagnosis - etiology |
5 |
|
lymphoma - diagnosis |
5 |
|
micrornas - genetics |
5 |
|
myelofibrosis |
5 |
|
next-generation sequencing |
5 |
|
piperazines - therapeutic use |
5 |
|
polymorphism, genetic |
5 |
|
primary |
5 |
|
protein transport |
5 |
|
pyrimidines - therapeutic use |
5 |
|
secondary |
5 |
|
stomach neoplasms - genetics |
5 |
|
survival rate |
5 |
|
allogeneic bone marrow transplantation |
4 |
|
aortic aneurysm, abdominal - complications - diagnosis - pathology - therapy |
4 |
|
arsenic trioxide |
4 |
|
arsenicals - therapeutic use |
4 |
|
azacitidine - analogs & derivatives - pharmacology |
4 |
|
bone marrow transplantation |
4 |
|
bone marrow transplantation - statistics & numerical data |
4 |
|
china |
4 |
|
chromosome deletion |
4 |
|
chromosomes, human, pair 9 - genetics |
4 |
|
dna, viral - analysis |
4 |
|
endocarditis, bacterial - complications - diagnosis - therapy |
4 |
|
epigenesis, genetic |
4 |
|
epigenesis, genetic - drug effects - physiology |
4 |
|
epigenetics |
4 |
|
epstein-barr virus infections - complications - drug therapy - pathology |
4 |
|
fetal hemoglobin - genetics - metabolism |
4 |
|
fungi - isolation and purification |
4 |
|
gene expression regulation, neoplastic - drug effects |
4 |
|
gene silencing |
4 |
|
gene silencing - drug effects - physiology |
4 |
|
hematopoietic stem cell transplantation - adverse effects |
4 |
|
herpesvirus 4, human - isolation & purification - physiology |
4 |
|
hodgkin disease - drug therapy - pathology - virology |
4 |
|
hox |
4 |
|
hypermethylation |
4 |
|
infant |
4 |
|
leukaemia |
4 |
|
leukemia, promyelocytic, acute - drug therapy - mortality - therapy |
4 |
|
lymphoma, large b-cell, diffuse - drug therapy - pathology - virology |
4 |
|
microrna |
4 |
|
mir203 |
4 |
|
mll-een |
4 |
|
multiple myeloma - complications - diagnosis - pathology - therapy |
4 |
|
multiple myeloma - etiology - genetics |
4 |
|
multiple myeloma - genetics - pathology |
4 |
|
myeloma |
4 |
|
neoplasms, multiple primary |
4 |
|
oxides - therapeutic use |
4 |
|
pneumococcal infections - complications - diagnosis - pathology - therapy |
4 |
|
polymorphism, single nucleotide - genetics |
4 |
|
prevalence |
4 |
|
primary cell culture |
4 |
|
receptors, antigen, t-cell, gamma-delta - genetics |
4 |
|
recurrence - prevention & control |
4 |
|
relapse |
4 |
|
remission induction |
4 |
|
retrospective studies |
4 |
|
tumor cells, cultured |
4 |
|
tumour suppressor |
4 |
|
young adult |
4 |
|
acute myeloid leukemia |
3 |
|
acute promyelocytic leukemia |
3 |
|
anemia, hemolytic - diagnosis - etiology |
3 |
|
anemia, refractory - diagnosis - etiology - therapy |
3 |
|
antigens, cd20 - analysis |
3 |
|
antigens, cd4 - analysis |
3 |
|
antigens, cd56 - analysis |
3 |
|
apoptosis |
3 |
|
asian continental ancestry group - genetics |
3 |
|
beta-globins - genetics |
3 |
|
beta-thalassemia - blood - epidemiology - genetics |
3 |
|
beta-thalassemia - genetics |
3 |
|
biopsy, needle |
3 |
|
blood transfusion |
3 |
|
cd4/cd56 |
3 |
|
cell transformation, neoplastic |
3 |
|
chinese children |
3 |
|
chromosome aberrations |
3 |
|
chromosome banding |
3 |
|
chromosomes, human, pair 22 - genetics |
3 |
|
chromosomes, human, pair 7 - genetics |
3 |
|
chromosomes, human, x |
3 |
|
chronic myeloid leukemia |
3 |
|
cohort studies |
3 |
|
dendritic cells - metabolism - pathology |
3 |
|
deoxyribonucleases, type ii site-specific |
3 |
|
diabetes insipidus |
3 |
|
dna primers |
3 |
|
dna, intergenic - genetics |
3 |
|
epidemiology |
3 |
|
erythrocytes, abnormal - ultrastructure |
3 |
|
fetal diseases - diagnosis - enzymology - genetics |
3 |
|
fetal hemoglobin - analysis |
3 |
|
fetal hemoglobin - genetics |
3 |
|
fusion proteins, bcr-abl - genetics |
3 |
|
gene expression regulation |
3 |
|
gene rearrangement |
3 |
|
genes, myb |
3 |
|
genes, p53 |
3 |
|
glucosephosphate dehydrogenase - blood - genetics |
3 |
|
glucosephosphate dehydrogenase deficiency - genetics |
3 |
|
granulocytic sarcoma |
3 |
|
hematology |
3 |
|
hemoglobin a2 - metabolism |
3 |
|
hemolytic-uremic syndrome |
3 |
|
hemolytic-uremic syndrome - microbiology |
3 |
|
heterozygote detection |
3 |
|
hong kong - epidemiology |
3 |
|
hyperplasia |
3 |
|
immunohistochemistry |
3 |
|
in situ hybridization, fluorescence |
3 |
|
inheritance patterns |
3 |
|
jmml |
3 |
|
leukemia, myelogenous, chronic, bcr-abl positive - blood - drug therapy - genetics - pathology |
3 |
|
leukemia, myeloid, acute - genetics |
3 |
|
leukemia, myeloid, acute - genetics - pathology |
3 |
|
linkage disequilibrium |
3 |
|
liver cirrhosis, alcoholic - complications |
3 |
|
lymphoma, b-cell - genetics - metabolism - pathology |
3 |
|
masquerade |
3 |
|
medicine & public health |
3 |
|
megakaryocytes - pathology |
3 |
|
monosomy 7 |
3 |
|
neoplasm recurrence, local |
3 |
|
neoplastic stem cells - metabolism - pathology |
3 |
|
neurofibromatosis |
3 |
|
neutropenia - drug therapy |
3 |
|
octamer transcription factor-2 - analysis |
3 |
|
oncogene proteins, fusion - genetics |
3 |
|
oncology |
3 |
|
phenotype |
3 |
|
plasmacytoid dendritic cell tumor |
3 |
|
pneumococcal infections |
3 |
|
pneumococcal infections - complications - microbiology |
3 |
|
prenatal diagnosis |
3 |
|
protein kinase inhibitors - therapeutic use |
3 |
|
protein-tyrosine kinases - antagonists & inhibitors |
3 |
|
pyruvate kinase - deficiency - genetics |
3 |
|
pyruvate kinase deficiency |
3 |
|
quantitative trait loci - genetics |
3 |
|
receptors, androgen - genetics |
3 |
|
reference values |
3 |
|
respiratory insufficiency - microbiology |
3 |
|
respiratory tract infections - microbiology |
3 |
|
restriction mapping |
3 |
|
reverse transcriptase polymerase chain reaction |
3 |
|
sensitivity and specificity |
3 |
|
sequence deletion |
3 |
|
serotyping |
3 |
|
severe congenital neutropenia |
3 |
|
siblings |
3 |
|
streptococcus pneumoniae |
3 |
|
streptococcus pneumoniae - classification - isolation and purification |
3 |
|
tissue donors - statistics & numerical data |
3 |
|
translocation, genetic |
3 |
|
vaccination |
3 |
|
von willebrand disease |
3 |
|
9q34 deletion |
2 |
|
acute disease |
2 |
|
african americans - genetics |
2 |
|
allele-specific priming |
2 |
|
alpha-thalassemia - blood - diagnosis - genetics |
2 |
|
alpha-thalassemia - ethnology - genetics |
2 |
|
anemia - genetics - physiopathology |
2 |
|
anemia, sickle cell - genetics - metabolism |
2 |
|
anemia, sideroblastic - etiology - physiopathology - therapy |
2 |
|
anoxia - diagnosis - etiology |
2 |
|
anti-lepore |
2 |
|
antigens, cd34 - metabolism |
2 |
|
antigens, cd38 - metabolism |
2 |
|
antineoplastic agents - therapeutic use |
2 |
|
apoptosis - physiology |
2 |
|
asian continental ancestry group |
2 |
|
basophils - pathology |
2 |
|
beta-thalassemia - blood - genetics |
2 |
|
beta-thalassemia - diagnosis - genetics |
2 |
|
beta-thalassemia - ethnology - genetics |
2 |
|
beta-thalassemia - genetics - metabolism |
2 |
|
blast crisis |
2 |
|
blast crisis - genetics |
2 |
|
bone marrow |
2 |
|
bone marrow neoplasms - genetics |
2 |
|
carrier proteins - genetics |
2 |
|
cell cycle - physiology |
2 |
|
cell line |
2 |
|
cell nucleus - ultrastructure |
2 |
|
cell proliferation |
2 |
|
chromatography, high pressure liquid |
2 |
|
chromosome disorders |
2 |
|
chromosomes, human, pair 1 |
2 |
|
chromosomes, human, pair 1 - genetics |
2 |
|
chromosomes, human, pair 11 |
2 |
|
chromosomes, human, pair 12 |
2 |
|
chromosomes, human, pair 17 |
2 |
|
chromosomes, human, pair 20 |
2 |
|
chromosomes, human, pair 21 |
2 |
|
chromosomes, human, pair 22 |
2 |
|
chromosomes, human, pair 3 |
2 |
|
chromosomes, human, pair 7 |
2 |
|
chromosomes, human, pair 8 |
2 |
|
chromosomes, human, pair 9 |
2 |
|
chronic myelogenous leukaemia |
2 |
|
chronic myeloid leukaemia |
2 |
|
clone cells |
2 |
|
cmml |
2 |
|
codon |
2 |
|
colony-forming units assay |
2 |
|
comparative genomic hybridization |
2 |
|
core binding factor alpha 2 subunit |
2 |
|
cyclin d1 |
2 |
|
cytogenetic analysis |
2 |
|
cytogenetic analysis - methods |
2 |
|
d-fish |
2 |
|
delta-chain |
2 |
|
delta-globins - genetics |
2 |
|
dendritic cells - metabolism |
2 |
|
differentiation |
2 |
|
dna ploidy |
2 |
|
dna primers - genetics |
2 |
|
dna probes - chemistry |
2 |
|
dna-binding proteins - genetics |
2 |
|
electrophoresis |
2 |
|
erythrocytes - ultrastructure |
2 |
|
fluorescence in situ hybridization |
2 |
|
fluorescent antibody technique |
2 |
|
fluorescent dyes - pharmacology |
2 |
|
follow-up studies |
2 |
|
gene deletion |
2 |
|
gene expression regulation - genetics |
2 |
|
gene fusion |
2 |
|
genes, abl |
2 |
|
genetic association studies |
2 |
|
genetic marker |
2 |
|
genetic variation |
2 |
|
globins - analysis |
2 |
|
globins - genetics |
2 |
|
granulocyte colony-stimulating factor - administration & dosage |
2 |
|
haemoglobin |
2 |
|
hairy cell leukaemia |
2 |
|
hbe trait |
2 |
|
hbf quantitative trait locus |
2 |
|
hbh inclusion test |
2 |
|
hemangiosarcoma - genetics |
2 |
|
hematopoietic stem cells |
2 |
|
hemoglobin a2 - genetics |
2 |
|
hemoglobinopathies - complications - diagnosis |
2 |
|
hemoglobinopathies - genetics - metabolism |
2 |
|
hemoglobins, abnormal - analysis - genetics |
2 |
|
hemoglobins, abnormal - genetics |
2 |
|
high resolution melting |
2 |
|
hong kong |
2 |
|
in situ hybridization, fluorescence - instrumentation - methods |
2 |
|
in situ hybridization, fluorescence - methods |
2 |
|
inclusion bodies - pathology |
2 |
|
interphase |
2 |
|
introns |
2 |
|
isochromosome 17q |
2 |
|
janus kinase 2 |
2 |
|
kidney failure, chronic - diagnosis - therapy |
2 |
|
large cell transformation |
2 |
|
leukemia, myelogenous, chronic, bcr-abl positive - diagnosis |
2 |
|
leukemia, myelogenous, chronic, bcr-abl positive - diagnosis - genetics - pathology |
2 |
|
leukemia, myelogenous, chronic, bcr-abl positive - ethnology - genetics |
2 |
|
leukemia, myelogenous, chronic, bcr-abl positive - genetics - immunology - pathology |
2 |
|
leukemia, myelogenous, chronic, bcr-abl positive - genetics - pathology |
2 |
|
leukemia, myeloid - drug therapy - genetics |
2 |
|
leukemia, myeloid, acute - metabolism - pathology |
2 |
|
leukemia, myelomonocytic, chronic - genetics |
2 |
|
leukemia, myelomonocytic, chronic - metabolism - pathology |
2 |
|
leukemia, promyelocytic, acute - diagnosis |
2 |
|
lymphocyte activation - genetics |
2 |
|
lymphoma, b-cell - diagnosis - pathology |
2 |
|
mantle cell lymphoma |
2 |
|
masked β-thalassemia (β-thal) |
2 |
|
membrane glycoproteins - metabolism |
2 |
|
morphology |
2 |
|
multigene family - genetics |
2 |
|
multiple myeloma |
2 |
|
mutation, missense - genetics |
2 |
|
mycosis fungoides |
2 |
|
mycosis fungoides - genetics - pathology |
2 |
|
myelodysplastic syndromes - complications - diagnosis - genetics |
2 |
|
myelodysplastic syndromes - diagnosis - genetics |
2 |
|
myelodysplastic syndromes - genetics |
2 |
|
myelodysplastic syndromes - genetics - pathology |
2 |
|
myeloproliferation |
2 |
|
myeloproliferative disorders - diagnosis |
2 |
|
myeloproliferative disorders - genetics - pathology |
2 |
|
neoplasms, multiple primary - genetics - pathology |
2 |
|
nuclear proteins - genetics |
2 |
|
nucleic acid hybridization |
2 |
|
oncogene proteins - genetics |
2 |
|
oximetry |
2 |
|
oxygen - blood |
2 |
|
oxygen - metabolism |
2 |
|
paranasal sinus neoplasms - genetics |
2 |
|
peritoneal dialysis, continuous ambulatory - adverse effects - methods |
2 |
|
philadelphia chromosome |
2 |
|
ploidies |
2 |
|
pml-rarα |
2 |
|
point mutation |
2 |
|
polycythemia |
2 |
|
polymerase chain reaction - methods |
2 |
|
polymorphism, single nucleotide |
2 |
|
polyploidy |
2 |
|
precursor cell lymphoblastic leukemia-lymphoma - genetics |
2 |
|
pregnancy |
2 |
|
primary myelofibrosis - complications - diagnosis - genetics |
2 |
|
proliferation |
2 |
|
protein-tyrosine kinases |
2 |
|
protein-tyrosine kinases - genetics |
2 |
|
proto-oncogene proteins |
2 |
|
proto-oncogene proteins - genetics |
2 |
|
proto-oncogene proteins c-bcr |
2 |
|
pyridoxine - deficiency |
2 |
|
quantitative trait loci |
2 |
|
radiotherapy |
2 |
|
renal dialysis - adverse effects - methods |
2 |
|
replating |
2 |
|
sequencing |
2 |
|
sezary syndrome - genetics - pathology |
2 |
|
sickle cell anemia |
2 |
|
skin neoplasms - genetics - pathology |
2 |
|
sphenoid sinus |
2 |
|
sézary syndrome |
2 |
|
thailand |
2 |
|
thalassaemia |
2 |
|
thalassemia - blood - genetics |
2 |
|
tp53 mutation |
2 |
|
transcription factors - genetics |
2 |
|
translocation, genetic - genetics |
2 |
|
tumor necrosis factor-alpha - pharmacology |
2 |
|
variant |
2 |
|
α thalassaemia |
2 |
|
β-thalassemia trait |
2 |
|
δ-globin variant |
2 |
|
ζ chains |
2 |
|
abo blood-group system |
1 |
|
adrenal gland neoplasms - complications - diagnosis |
1 |
|
ahsp |
1 |
|
alloantibodies |
1 |
|
alloimmunization |
1 |
|
alpha-thalassemia |
1 |
|
amsacrine - administration & dosage |
1 |
|
anemia, dyserythropoietic, congenital - genetics |
1 |
|
anemia, hemolytic, autoimmune - epidemiology - etiology - immunology |
1 |
|
anemia, iron-deficiency - etiology |
1 |
|
anemia, refractory, with excess of blasts - genetics |
1 |
|
anemia, sickle cell - genetics |
1 |
|
animals |
1 |
|
antenatal screen |
1 |
|
antibodies, anti-idiotypic - immunology - isolation & purification |
1 |
|
antibody specificity |
1 |
|
anticonvulsants - adverse effects |
1 |
|
antifungal agents - therapeutic use |
1 |
|
antigens, cd3 - metabolism |
1 |
|
antigens, cd31 - analysis |
1 |
|
antigens, cd5 - biosynthesis |
1 |
|
antigens, cd56 - metabolism |
1 |
|
antigens, cd8 - metabolism |
1 |
|
antineoplastic combined chemotherapy protocols - administration & dosage - therapeutic use |
1 |
|
autoantibodies |
1 |
|
autoantibodies - immunology |
1 |
|
autoimmune diseases - epidemiology - etiology - immunology |
1 |
|
autologous stem cell transplantation |
1 |
|
b-cell lymphoma |
1 |
|
beta-thalassemia - complications - diagnosis |
1 |
|
biomarker |
1 |
|
biopsy |
1 |
|
bleomycin - administration & dosage |
1 |
|
blood |
1 |
|
blood cell count |
1 |
|
blood group incompatibility - epidemiology - immunology |
1 |
|
blood grouping and crossmatching |
1 |
|
blood platelets - pathology |
1 |
|
blood transfusion - adverse effects |
1 |
|
bone marrow - chemistry - pathology |
1 |
|
bone marrow cells |
1 |
|
bone marrow examination |
1 |
|
bone marrow transplantation - adverse effects |
1 |
|
cancer |
1 |
|
cd4-positive t-lymphocytes - physiology |
1 |
|
cd56 |
1 |
|
cell differentiation |
1 |
|
cell lineage |
1 |
|
cell nucleolus - pathology |
1 |
|
cerebellar neoplasms - blood - diagnosis - pathology |
1 |
|
chemotherapy, adjuvant |
1 |
|
china - epidemiology |
1 |
|
china - ethnology |
1 |
|
chromosome aberrations - pathology |
1 |
|
chromosome inversion |
1 |
|
chromosome mapping |
1 |
|
chromosomes, human, pair 10 |
1 |
|
chromosomes, human, pair 10 - genetics |
1 |
|
chromosomes, human, pair 12 - genetics |
1 |
|
chromosomes, human, pair 13 |
1 |
|
chromosomes, human, pair 13 - genetics |
1 |
|
chromosomes, human, pair 14 |
1 |
|
chromosomes, human, pair 17 - genetics |
1 |
|
chromosomes, human, pair 2 |
1 |
|
chromosomes, human, pair 2 - genetics |
1 |
|
chromosomes, human, pair 3 - genetics |
1 |
|
chromosomes, human, pair 4 - genetics |
1 |
|
chromosomes, human, pair 6 |
1 |
|
chronic lymphoproliferative disorder |
1 |
|
clinical enzyme tests |
1 |
|
clone cells - immunology - pathology |
1 |
|
coombs' test |
1 |
|
cyclin d1 - biosynthesis |
1 |
|
cyclin d1 - metabolism |
1 |
|
cyclophosphamide - administration & dosage |
1 |
|
cytarabine - administration & dosage |
1 |
|
cytology |
1 |
|
cytomegalovirus infections - complications - pathology |
1 |
|
direct antiglobulin test |
1 |
|
disease severity |
1 |
|
donor selection |
1 |
|
dysmyelopoiesis |
1 |
|
ebv |
1 |
|
ebv-encoded early rna |
1 |
|
economics |
1 |
|
elderly |
1 |
|
epilepsy - complications - drug therapy |
1 |
|
epirubicin - administration & dosage |
1 |
|
epstein-barr virus |
1 |
|
erythroblastosis, fetal - blood - diagnosis |
1 |
|
erythroblastosis, fetal - prevention & control |
1 |
|
erythrocytosis |
1 |
|
etoposide - administration & dosage |
1 |
|
exchange transfusion, whole blood |
1 |
|
extramedullary haemopoiesis |
1 |
|
familial leukaemia |
1 |
|
fatal outcome |
1 |
|
ferritin |
1 |
|
fibroblasts |
1 |
|
fibroblasts - pathology |
1 |
|
gastrointestinal neoplasms |
1 |
|
gastrointestinal neoplasms - pathology |
1 |
|
gene duplication |
1 |
|
gene rearrangement, t-lymphocyte |
1 |
|
genes, tumor suppressor |
1 |
|
globin |
1 |
|
glucosephosphate dehydrogenase deficiency |
1 |
|
glucosephosphate dehydrogenase deficiency - ethnology - genetics |
1 |
|
glycogen storage disease type i - complications - diagnosis - genetics |
1 |
|
haemolytic disease of the newborn |
1 |
|
hb tarrant |
1 |
|
hbh disease |
1 |
|
hemangioblastoma - blood - diagnosis - pathology |
1 |
|
hemangiosarcoma - immunology - pathology |
1 |
|
hematocrit |
1 |
|
hematologic toxicity |
1 |
|
hematopoiesis, extramedullary - radiation effects |
1 |
|
hematopoietic stem cell transplantation |
1 |
|
hematopoietic stem cell transplantation (hsct) |
1 |
|
hematopoietic stem cell transplantation - ethnology |
1 |
|
hematopoietic stem cells - enzymology |
1 |
|
hemoglobin a |
1 |
|
hemoglobin a, glycosylated - analysis |
1 |
|
hemoglobin a2 |
1 |
|
hemoglobin f |
1 |
|
hemoglobin, sickle - genetics |
1 |
|
high oxygen affinity hemoglobin (hb) |
1 |
|
hiv seropositivity - complications - microbiology |
1 |
|
hyperbilirubinemia - therapy |
1 |
|
hypotension - etiology |
1 |
|
idiopathic myelofibrosis |
1 |
|
immunization |
1 |
|
immunoenzyme techniques |
1 |
|
immunoglobulin g |
1 |
|
immunoglobulin m - blood |
1 |
|
in situ hybridization |
1 |
|
infant, newborn |
1 |
|
infant, premature |
1 |
|
infant, premature, diseases - pathology |
1 |
|
infantile |
1 |
|
interferon-alpha - therapeutic use |
1 |
|
intestinal neoplasms - complications - drug therapy |
1 |
|
isoantibodies - analysis |
1 |
|
isoantibodies - immunology - isolation & purification |
1 |
|
itraconazole - therapeutic use |
1 |
|
jaundice - blood - therapy |
1 |
|
killer cells, natural |
1 |
|
killer cells, natural - chemistry - pathology |
1 |
|
leukemia |
1 |
|
leukemia - genetics |
1 |
|
leukemia - metabolism - pathology |
1 |
|
leukemia, hairy cell - diagnosis |
1 |
|
leukemia, lymphoid - diagnosis - etiology - pathology |
1 |
|
leukemia, lymphoid - genetics |
1 |
|
leukemia, lymphoid - genetics - pathology |
1 |
|
leukemia, myeloid - genetics |
1 |
|
leukemia, myeloid - genetics - pathology |
1 |
|
leukemia, plasma cell - therapy |
1 |
|
leukemia, prolymphocytic - diagnosis |
1 |
|
leukemia-lymphoma, adult t-cell - genetics |
1 |
|
leukocytes - ultrastructure |
1 |
|
lymph node |
1 |
|
lymph nodes - pathology |
1 |
|
lymphatic diseases - etiology - pathology |
1 |
|
lymphocyte activation |
1 |
|
lymphocytosis - diagnosis - etiology - pathology |
1 |
|
lymphoma - chemistry - pathology - therapy |
1 |
|
lymphoma, b-cell - genetics - immunology |
1 |
|
lymphoma, b-cell - genetics - pathology |
1 |
|
lymphoma, mantle-cell - classification - diagnosis - metabolism |
1 |
|
lymphoma, non-hodgkin - genetics - pathology |
1 |
|
lymphoma, non-hodgkin - metabolism - pathology - ultrastructure |
1 |
|
lymphoma, t-cell - complications - drug therapy |
1 |
|
lymphoproliferative disorders - genetics - immunology |
1 |
|
malignant lymphoma |
1 |
|
mass screening |
1 |
|
methotrexate - administration & dosage |
1 |
|
molecular remission |
1 |
|
monosomy |
1 |
|
monosomy-7 |
1 |
|
multigene family |
1 |
|
multiple myeloma - immunology - pathology |
1 |
|
mycoses - complications - drug therapy - microbiology |
1 |
|
myelodysplasia |
1 |
|
myelodysplastic syndromes - chemically induced - pathology |
1 |
|
myelodysplastic syndromes - diagnosis - genetics - pathology |
1 |
|
myeloproliferative disease |
1 |
|
nasal lymphoma |
1 |
|
nasopharyngeal lymphoma |
1 |
|
natural killer cell |
1 |
|
neoplasms, second primary - pathology |
1 |
|
nk cell lymphoma |
1 |
|
nondeletional hb h disease |
1 |
|
nose neoplasms - chemistry - pathology - therapy |
1 |
|
novel mutation |
1 |
|
nucleolated variant |
1 |
|
opportunistic infections - complications - drug therapy - microbiology |
1 |
|
osteoblasts - immunology - pathology |
1 |
|
paranasal sinus neoplasms - immunology - pathology |
1 |
|
penicillium |
1 |
|
peripheral blood stem cell transplantation - methods |
1 |
|
pheochromocytoma - complications - diagnosis |
1 |
|
plasma cell leukaemia |
1 |
|
polyadenylation (polya) signal mutation |
1 |
|
polycythemia - etiology |
1 |
|
prednisone - administration & dosage |
1 |
|
prenatal diagnosis - methods |
1 |
|
primary myelofibrosis - etiology - pathology |
1 |
|
prolymphocytic leukemia |
1 |
|
puerperal |
1 |
|
puerperal disorders - genetics |
1 |
|
rats |
1 |
|
remission induction - methods |
1 |
|
respiratory distress syndrome, adult - etiology |
1 |
|
reticulocyte count - instrumentation - methods |
1 |
|
rh-hr blood-group system - immunology |
1 |
|
rna, viral - analysis |
1 |
|
screening |
1 |
|
severe α-thalassemia (α-thal) |
1 |
|
shock, septic - diagnosis |
1 |
|
skull neoplasms - immunology - pathology |
1 |
|
sodium valproate |
1 |
|
spherocytes - pathology |
1 |
|
spherocytosis, hereditary - blood |
1 |
|
splenomegaly - etiology |
1 |
|
standard of care |
1 |
|
stroke |
1 |
|
stroke rehabilitation |
1 |
|
stromal cells |
1 |
|
stromal cells - pathology |
1 |
|
t(11;14) |
1 |
|
t-lymphocytes - immunology - pathology |
1 |
|
temperature |
1 |
|
thrombocytopenia - pathology |
1 |
|
transplantation, autologous |
1 |
|
transplantation, homologous |
1 |
|
treatment outcome |
1 |
|
trisomy |
1 |
|
urinary bladder |
1 |
|
urinary bladder neoplasms - etiology - pathology - radiotherapy |
1 |
|
valproic acid - adverse effects |
1 |
|
vincristine - administration & dosage |
1 |
|
waldenstrom macroglobulinemia - blood - diagnosis - genetics |
1 |
|
warm-type |
1 |
|
x chromosome |
1 |
|
x chromosome - genetics |
1 |
|
α-globin gene |
1 |
